A citation-based method for searching scientific literature

Alex Mas Monteys, Shauna A Ebanks, Megan S Keiser, Beverly L Davidson. Mol Ther 2017
Times Cited: 136



Chengzu Long, Leonela Amoasii, Alex A Mireault, John R McAnally, Hui Li, Efrain Sanchez-Ortiz, Samadrita Bhattacharyya, John M Shelton, Rhonda Bassel-Duby, Eric N Olson. Science 2016
Times Cited: 547




List of shared articles



Times cited

CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases.
Garima Sharma, Ashish Ranjan Sharma, Manojit Bhattacharya, Sang-Soo Lee, Chiranjib Chakraborty. Mol Ther 2021
10

Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect.
Yu-Fan Chuang, Andrew J Phipps, Fan-Li Lin, Valerie Hecht, Alex W Hewitt, Peng-Yuan Wang, Guei-Sheung Liu. Cell Mol Life Sci 2021
4

CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing.
Ishani Dasgupta, Terence R Flotte, Allison M Keeler. Hum Gene Ther 2021
6

A glance at genome editing with CRISPR-Cas9 technology.
Antara Barman, Bornali Deb, Supriyo Chakraborty. Curr Genet 2020
13

Genome editing methods in animal models.
Hyunji Lee, Da Eun Yoon, Kyoungmi Kim. Anim Cells Syst (Seoul) 2020
11

The delivery challenge: fulfilling the promise of therapeutic genome editing.
Joost van Haasteren, Jie Li, Olivia J Scheideler, Niren Murthy, David V Schaffer. Nat Biotechnol 2020
39

The Impact of CRISPR-Cas9 on Age-related Disorders: From Pathology to Therapy.
Allen Caobi, Rajib Kumar Dutta, Luis D Garbinski, Maria Esteban-Lopez, Yasemin Ceyhan, Mickensone Andre, Marko Manevski, Chet Raj Ojha, Jessica Lapierre, Sneham Tiwari,[...]. Aging Dis 2020
2

Delivery Approaches for Therapeutic Genome Editing and Challenges.
Ilayda Ates, Tanner Rathbone, Callie Stuart, P Hudson Bridges, Renee N Cottle. Genes (Basel) 2020
13

Trinucleotide repeat instability during double-strand break repair: from mechanisms to gene therapy.
Valentine Mosbach, Lucie Poggi, Guy-Franck Richard. Curr Genet 2019
11

Basic and Clinical Application of Adeno-Associated Virus-Mediated Genome Editing.
Xiubin He, Haihua Xie, Xiexie Liu, Feng Gu. Hum Gene Ther 2019
3

Design of AAV Vectors for Delivery of Large or Multiple Transgenes.
Aman Patel, Junling Zhao, Dongsheng Duan, Yi Lai. Methods Mol Biol 2019
16


Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases.
Panayiota Papasavva, Marina Kleanthous, Carsten W Lederer. Mol Diagn Ther 2019
12

Era of Genomic Medicine: A Narrative Review on CRISPR Technology as a Potential Therapeutic Tool for Human Diseases.
Odatha W Kotagama, Chanika D Jayasinghe, Thelma Abeysinghe. Biomed Res Int 2019
7

CRISPR editing in biological and biomedical investigation.
Jiaojiao Huang, Yanfang Wang, Jianguo Zhao. J Cell Physiol 2018
10

Immunity to CRISPR Cas9 and Cas12a therapeutics.
Wei Leong Chew. Wiley Interdiscip Rev Syst Biol Med 2018
59

In vivo genome editing thrives with diversified CRISPR technologies.
Xun Ma, Avery Sum-Yu Wong, Hei-Yin Tam, Samuel Yung-Kin Tsui, Dittman Lai-Shun Chung, Bo Feng. Zool Res 2018
8